- February 5, 2020
First Buy, Then Invest: Novartis, Gilead Join $35M Bet on Vineti’s Software
Publication: Timmerman Report
- February 5, 2020
Vineti Completes $35 Million in Series C Financing to Industrialize Personalized and High-Value Therapeutics
Press Release
- February 5, 2020
Vineti Gets $35 Million for Software That Serves Gene, Cell Therapy Markets
Publication: The Wall Street Journal
- February 5, 2020
Vineti raises $35M in Series C round, eyeing service, geographic expansion
Publication: MedCity News
- February 5, 2020
In quest to get right cells to the right cancer patients, ‘smart plumbing’ company raises $35M
Publication: San Francisco Business Times
- December 22, 2019
To make advanced therapies, we need to industrialize personalization
Press Release
- December 17, 2019
WoVen Podcast: Democratizing healthcare with activist roots – A conversation with Amy DuRoss
Press Release
- December 2, 2019
New Center Marks Aggressive Push into CGMP Manufacturing of Cell and Gene Therapies
Press Release
- November 6, 2019
Vineti and WuXi AppTec Advanced Therapies Collaborate to Simplify Manufacturing Supply Chain for Advanced Therapies
Press Release
We use cookies for analytics, marketing purposes, and to improve our site. You agree to our use of cookies by clicking yes. To find out more, including how to change your settings, see our privacy policy for details.